vs

Side-by-side financial comparison of Mama's Creations, Inc. (MAMA) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $47.3M, roughly 1.2× Mama's Creations, Inc.). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -83.0%, a 84.1% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs 36.9%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 33.0%).

Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

MAMA vs RYTM — Head-to-Head

Bigger by revenue
RYTM
RYTM
1.2× larger
RYTM
$57.3M
$47.3M
MAMA
Growing faster (revenue YoY)
MAMA
MAMA
+13.1% gap
MAMA
50.0%
36.9%
RYTM
Higher net margin
MAMA
MAMA
84.1% more per $
MAMA
1.1%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
33.0%
MAMA

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
MAMA
MAMA
RYTM
RYTM
Revenue
$47.3M
$57.3M
Net Profit
$540.0K
$-47.5M
Gross Margin
23.6%
91.6%
Operating Margin
1.7%
-82.2%
Net Margin
1.1%
-83.0%
Revenue YoY
50.0%
36.9%
Net Profit YoY
31.7%
-9.6%
EPS (diluted)
$0.01
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MAMA
MAMA
RYTM
RYTM
Q4 25
$47.3M
$57.3M
Q3 25
$35.2M
$51.3M
Q2 25
$35.3M
$48.5M
Q1 25
$33.6M
$32.7M
Q4 24
$31.5M
$41.8M
Q3 24
$28.4M
$33.3M
Q2 24
$29.8M
$29.1M
Q1 24
$26.7M
$26.0M
Net Profit
MAMA
MAMA
RYTM
RYTM
Q4 25
$540.0K
$-47.5M
Q3 25
$1.3M
$-52.9M
Q2 25
$1.2M
$-46.6M
Q1 25
$1.6M
$-49.5M
Q4 24
$410.0K
$-43.3M
Q3 24
$1.1M
$-43.6M
Q2 24
$553.0K
$-32.3M
Q1 24
$1.4M
$-141.4M
Gross Margin
MAMA
MAMA
RYTM
RYTM
Q4 25
23.6%
91.6%
Q3 25
24.9%
89.3%
Q2 25
26.1%
88.6%
Q1 25
27.0%
88.8%
Q4 24
22.6%
90.9%
Q3 24
24.2%
88.5%
Q2 24
25.0%
89.9%
Q1 24
29.3%
89.2%
Operating Margin
MAMA
MAMA
RYTM
RYTM
Q4 25
1.7%
-82.2%
Q3 25
4.8%
-102.6%
Q2 25
4.5%
-93.4%
Q1 25
5.7%
-143.7%
Q4 24
1.8%
-98.6%
Q3 24
5.7%
-132.0%
Q2 24
2.6%
-139.2%
Q1 24
7.4%
-538.7%
Net Margin
MAMA
MAMA
RYTM
RYTM
Q4 25
1.1%
-83.0%
Q3 25
3.6%
-103.1%
Q2 25
3.5%
-96.1%
Q1 25
4.8%
-151.4%
Q4 24
1.3%
-103.6%
Q3 24
4.0%
-131.2%
Q2 24
1.9%
-110.9%
Q1 24
5.3%
-544.4%
EPS (diluted)
MAMA
MAMA
RYTM
RYTM
Q4 25
$0.01
$-0.73
Q3 25
$0.03
$-0.82
Q2 25
$0.03
$-0.75
Q1 25
$0.04
$-0.81
Q4 24
$0.01
$-0.71
Q3 24
$0.03
$-0.73
Q2 24
$0.01
$-0.55
Q1 24
$0.03
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MAMA
MAMA
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$18.1M
$388.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$49.6M
$139.1M
Total Assets
$84.0M
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MAMA
MAMA
RYTM
RYTM
Q4 25
$18.1M
$388.9M
Q3 25
$9.4M
$416.1M
Q2 25
$12.0M
$291.0M
Q1 25
$7.2M
$314.5M
Q4 24
$9.3M
$320.6M
Q3 24
$7.4M
$298.4M
Q2 24
$13.0M
$319.1M
Q1 24
$11.0M
$201.2M
Stockholders' Equity
MAMA
MAMA
RYTM
RYTM
Q4 25
$49.6M
$139.1M
Q3 25
$29.6M
$148.8M
Q2 25
$26.4M
$-11.9M
Q1 25
$24.9M
$18.9M
Q4 24
$23.0M
$21.7M
Q3 24
$22.3M
$11.2M
Q2 24
$20.3M
$39.3M
Q1 24
$19.6M
$61.6M
Total Assets
MAMA
MAMA
RYTM
RYTM
Q4 25
$84.0M
$480.2M
Q3 25
$51.2M
$506.9M
Q2 25
$52.7M
$372.7M
Q1 25
$47.1M
$386.7M
Q4 24
$47.9M
$392.3M
Q3 24
$43.0M
$363.6M
Q2 24
$47.2M
$381.8M
Q1 24
$45.1M
$258.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MAMA
MAMA
RYTM
RYTM
Operating Cash FlowLast quarter
$3.9M
$-25.4M
Free Cash FlowOCF − Capex
$3.7M
FCF MarginFCF / Revenue
7.8%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
7.16×
TTM Free Cash FlowTrailing 4 quarters
$6.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MAMA
MAMA
RYTM
RYTM
Q4 25
$3.9M
$-25.4M
Q3 25
$-1.7M
$-26.6M
Q2 25
$6.0M
$-23.3M
Q1 25
$-857.0K
$-40.4M
Q4 24
$4.8M
$-18.8M
Q3 24
$-2.4M
$-25.2M
Q2 24
$3.6M
$-29.1M
Q1 24
$6.7M
$-40.7M
Free Cash Flow
MAMA
MAMA
RYTM
RYTM
Q4 25
$3.7M
Q3 25
$-2.2M
Q2 25
$5.5M
Q1 25
$-930.0K
Q4 24
$2.5M
Q3 24
$-4.0M
Q2 24
$2.5M
Q1 24
$6.6M
FCF Margin
MAMA
MAMA
RYTM
RYTM
Q4 25
7.8%
Q3 25
-6.2%
Q2 25
15.5%
Q1 25
-2.8%
Q4 24
8.0%
Q3 24
-14.1%
Q2 24
8.4%
Q1 24
24.8%
Capex Intensity
MAMA
MAMA
RYTM
RYTM
Q4 25
0.4%
Q3 25
1.5%
Q2 25
1.5%
Q1 25
0.2%
Q4 24
7.2%
Q3 24
5.6%
Q2 24
3.8%
Q1 24
0.4%
Cash Conversion
MAMA
MAMA
RYTM
RYTM
Q4 25
7.16×
Q3 25
-1.31×
Q2 25
4.85×
Q1 25
-0.54×
Q4 24
11.71×
Q3 24
-2.10×
Q2 24
6.58×
Q1 24
4.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons